These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10880664)

  • 1. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease.
    Sebregts EH; Falger PR; Bär FW
    J Psychosom Res; 2000; 48(4-5):425-41. PubMed ID: 10880664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of coronary heart disease.
    Zafari AM; Wenger NK
    Arch Phys Med Rehabil; 1998 Aug; 79(8):1006-17. PubMed ID: 9710178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of smoking cessation, physical training and psychological interventions in secondary prevention of coronary heart disease].
    Jost S
    Z Kardiol; 1994 Oct; 83(10):742-58. PubMed ID: 7810188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.
    Coukell AJ; Wilde MI
    Pharmacoeconomics; 1998 Aug; 14(2):217-36. PubMed ID: 10186462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic and resistive exercise modify risk factors for coronary heart disease.
    Goldberg AP
    Med Sci Sports Exerc; 1989 Dec; 21(6):669-74. PubMed ID: 2696854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral approaches to secondary prevention of coronary heart disease.
    Blumenthal JA; Levenson RM
    Circulation; 1987 Jul; 76(1 Pt 2):I130-7. PubMed ID: 3297396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention of coronary heart disease in elderly patients.
    Hanna IR; Wenger NK
    Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease.
    Tonstad S; Sundfør T; Seljeflot I
    Am J Cardiol; 2005 May; 95(10):1187-91. PubMed ID: 15877991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
    Frisinghelli A; Mafrici A
    Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?
    Montague T; Tsuyuki R; Burton J; Williams R; Dzavik V; Teo K
    Chest; 1994 Mar; 105(3):718-26. PubMed ID: 8131532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple risk factors for coronary artery disease: behavioral factors in preventive cardiology.
    Pearson TA
    Am J Cardiol; 1987 Dec; 60(18):74J-79J. PubMed ID: 3425558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy.
    Lewis SJ
    J Fam Pract; 2009 Nov; 58(11 Suppl Urgent):S32-40. PubMed ID: 19891946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial evaluation of a program for lifestyle behavior change in rehabilitation and secondary prevention of coronary artery disease.
    Lisspers J; Hofman-Bang C; Nordlander R; Rydèn L; Sundin O; Ohman A; Nygren A
    Scand Cardiovasc J; 1999; 33(1):9-16. PubMed ID: 10093853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.